Delivery Order SPE2DB24D8002-SPE2DB24FJMPZ
Award Date
7/18/24
Potential Completion Date
7/19/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D8001|SPE2DB24FKYWF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The $9,771.03 firm fixed-price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGEML. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBPZE, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $16,771.40 Firm Fixed Price Delivery Order contract is for the provision of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period through November 7, 2023. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZBM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,352.56 firm fixed-price delivery order is for the provision of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA...
This federal contract award, identified as SPE2DX15D8002|SPE2DX23F2XL4, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to the prime contractor Dakota Drug, Inc. The $8,963.87 firm fixed-price delivery order is for the procurement of STELARA 90 MG/ML syringes, a pharmaceutical product. The contract has a performance period extending through May 18, 2023 and is not a set-aside award. Dakota Drug, Inc. is a self-certified small disadvantaged business that...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZLG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $8,114.16 and a period of performance through March 28, 2025. It is a Firm Fixed Price Delivery Order contract,...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQKX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,091.23 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML pharmaceutical products. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, as part of the DLA Troop Support Medical's...
This federal contract award, identified as SPE2DB24D8002|SPE2DB24FJNAG, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $17,696.27 firm fixed-price contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a prescription medication. This award is a delivery order under Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop...
This federal contract award, with ID SPE2DB24D8001|SPE2DB24FKYYA, is a delivery order valued at $19,198.65 issued by the Defense Logistics Agency (DLA) to the prime contractor, Dakota Drug, Inc. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through August 20, 2024. This award is not associated with a...
This federal contract award, valued at $8,572.60, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order (SPE2DB25FJNBP) for 4567104271 STELARA 90 MG/ML SYRINGEML, with a performance period through January 31, 2025. Dakota Drug, Inc. is an established federal contractor, holding a significant Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999.00. This IDC, part of the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $20,476.24 firm fixed-price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGEML, with a period of performance through February 27, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's...